Researchers from Huazhong University of Science and Technology have described the potential use of RBM47 as a therapeutic target for thyroid-associated ophthalmopathy, an autoimmune disorder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback